UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients

Journal of clinical oncology, 2015-02, Vol.33 (6), p.643-650

2015

Volltextzugriff (PDF)

A contemporary review of management and prognostic factors of upper tract urothelial carcinoma

Cancer treatment reviews, 2015-04, Vol.41 (4), p.310-319

2015

Volltextzugriff (PDF)

Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer

Clinical genitourinary cancer, 2017-02, Vol.15 (1), p.145-151.e2

2017

Volltextzugriff (PDF)

Differential Expression Of Pd-L1 In High Grade T1 Vs Muscle Invasive Bladder Carcinoma And Its Prognostic Implications

The Journal of urology, 2017-10, Vol.198 (4), p.817-823

2017

Volltextzugriff (PDF)

A Clinical Decision Support System for Predicting Invasive Breast Cancer Recurrence: Preliminary Results

Frontiers in oncology, 2021-03, Vol.11, p.576007-576007

2021

Volltextzugriff (PDF)

Variant Forms of Bladder Cancer: Basic Considerations on Treatment Approaches

Current oncology reports, 2011-06, Vol.13 (3), p.216-221

2011

Volltextzugriff (PDF)

Molecular determinants of response to cisplatin-based neoadjuvant chemotherapy

Current opinion in urology, 2013-09, Vol.23 (5), p.466-471

2013

Volltextzugriff (PDF)

Present strategies in the treatment of metastatic renal cell carcinoma: an update on molecular targeting agents

BJU international, 2007-02, Vol.99 (2), p.274-280

2007

Volltextzugriff (PDF)

The “Artificial” Docetaxel Space: The Evolving Treatment Paradigm of Metastatic Castration-Resistant Prostate Cancer

European urology, 2015-01, Vol.67 (1), p.30-32

2015

Volltextzugriff (PDF)

Precision and Predictive Medicine in Urothelial Cancer: Are We Making Progress?

European urology, 2015-10, Vol.68 (4), p.547-549

2015

Volltextzugriff (PDF)

Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer

Cancer research (Chicago, Ill.), 2020-10, Vol.80 (20), p.4476-4486

2020

Volltextzugriff (PDF)

Reply to K. Lu

Journal of clinical oncology, 2015-08, Vol.33 (24), p.2716-2717

2015

Volltextzugriff (PDF)

Letter to the Editor, Re: van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernández PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer. 2016; 64:127–136

European journal of cancer (1990), 2016-11, Vol.68, p.196-197

2016

Volltextzugriff (PDF)

Redefining Clinically Significant Castration Levels in Patients With Prostate Cancer Receiving Continuous Androgen Deprivation Therapy

The Journal of urology, 2007-10, Vol.178 (4), p.1290-1295

2007

Volltextzugriff (PDF)

New steps on an old path: Novel estrogen receptor inhibitors in breast cancer

Critical reviews in oncology/hematology, 2022-12, Vol.180, p.103861-103861, Article 103861

2022

Volltextzugriff (PDF)

Differential expression of SRSF2 contribute to the splicing changes related to micropapillary variant histology in nonmuscle-invasive bladder cancer (NMIBC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16520-e16520

2018

Volltextzugriff (PDF)

Role of inflammation in the perioperative management of urothelial bladder cancer with squamous cell features; impact of neutrophil-to-lymphocyte ratio on outcomes and response to neoadjuvant chemotherapy

Clinical genitourinary cancer, 2017-08, Vol.15 (4), p.e697-e706

2017

Volltextzugriff (PDF)

Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer

Scientific reports, 2020-11, Vol.10 (1), p.20135-20135, Article 20135

2020

Volltextzugriff (PDF)

Differential expression of PD-L1 expression in high grade T1 (HGT1) v. muscle invasive urothelial carcinoma (MIUC) and its prognostic implications

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4535-4535

2016

Volltextzugriff (PDF)

Genomic predictors of recurrence (R) or progression (P) in high grade T1 (HGT1) non-muscle invasive (NMI) bladder cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4539-4539

2016

Volltextzugriff (PDF)

Genomic landscape of micropapillary nonmuscle-invasive bladder cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e16028-e16028

2016

Volltextzugriff (PDF)

Prevalence of Osteoporosis During Long-Term Androgen Deprivation Therapy in Patients with Prostate Cancer

Urology (Ridgewood, N.J.), 2007-03, Vol.69 (3), p.500-504

2007

Volltextzugriff (PDF)

Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:378–84

European urology, 2012-06, Vol.61 (6), p.e53-e54

2012

Volltextzugriff (PDF)

Fixed tissue ChIP-seq (FiT-Seq) of archived FFPE clinical bladder cancer (BC) samples to reveal tumor-specific enhancer and super-enhancer profiles

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4541-4541

2016

Volltextzugriff (PDF)

MP56-14 ACTIVE SURVEILLANCE IN LOW RISK BLADDER CANCER. WHEN TUR IS RECOMMENDED?

The Journal of urology, 2014-04, Vol.191 (4), p.e569-e569

2014

Volltextzugriff (PDF)

1 – 25 von 191

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(156)

Publikationsform

Artikel
(189)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients

A contemporary review of management and prognostic factors of upper tract urothelial carcinoma

Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer

Differential Expression Of Pd-L1 In High Grade T1 Vs Muscle Invasive Bladder Carcinoma And Its Prognostic Implications

A Clinical Decision Support System for Predicting Invasive Breast Cancer Recurrence: Preliminary Results

Variant Forms of Bladder Cancer: Basic Considerations on Treatment Approaches

Molecular determinants of response to cisplatin-based neoadjuvant chemotherapy

Present strategies in the treatment of metastatic renal cell carcinoma: an update on molecular targeting agents

The “Artificial” Docetaxel Space: The Evolving Treatment Paradigm of Metastatic Castration-Resistant Prostate Cancer

Precision and Predictive Medicine in Urothelial Cancer: Are We Making Progress?

Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer

Reply to K. Lu

Letter to the Editor, Re: van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernández PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer. 2016; 64:127–136

Redefining Clinically Significant Castration Levels in Patients With Prostate Cancer Receiving Continuous Androgen Deprivation Therapy

New steps on an old path: Novel estrogen receptor inhibitors in breast cancer

Differential expression of SRSF2 contribute to the splicing changes related to micropapillary variant histology in nonmuscle-invasive bladder cancer (NMIBC)

Role of inflammation in the perioperative management of urothelial bladder cancer with squamous cell features; impact of neutrophil-to-lymphocyte ratio on outcomes and response to neoadjuvant chemotherapy

Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer

Differential expression of PD-L1 expression in high grade T1 (HGT1) v. muscle invasive urothelial carcinoma (MIUC) and its prognostic implications

Genomic predictors of recurrence (R) or progression (P) in high grade T1 (HGT1) non-muscle invasive (NMI) bladder cancer

Genomic landscape of micropapillary nonmuscle-invasive bladder cancer

Prevalence of Osteoporosis During Long-Term Androgen Deprivation Therapy in Patients with Prostate Cancer

Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:378–84

Fixed tissue ChIP-seq (FiT-Seq) of archived FFPE clinical bladder cancer (BC) samples to reveal tumor-specific enhancer and super-enhancer profiles

MP56-14 ACTIVE SURVEILLANCE IN LOW RISK BLADDER CANCER. WHEN TUR IS RECOMMENDED?

Suchergebnisse filtern